Prostate cancer originates in the male prostate gland and has become one of the most common types of cancer. It typically remains confined in this region, however it may spread to other locations throughout the body. Risk of prostate cancer increases with age, family history, obesity, and ethnicity as black males are the most likely to develop prostate cancer. Treatment for prostate cancer includes radiation therapy, hormone therapy, surgery, and chemotherapy. In stage IV of prostate cancer, the most advanced and aggressive stage, PSA can be at any level and the Gleason score ranges from 2-10. Additionally, cancer has spread to nearby tissue and organs (rectum, bladder, pelvic wall), nearby lymph nodes, or to distant locations like bones.
Stage D Prostate Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage D Prostate Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 808 products for the study of Stage D Prostate Cancer that can be applied to Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence from our catalog of antibodies and ELISA kits.